Essential Partners
GSK icon

Essential Partners’s GSK GSK Stock Holding History

Essential Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.9K Hold
414
– – 0.01% 911
2026
Q2 		$21.7K Hold
414
– – 0.01% 873
2026
Q1 		$22.8K Hold
414
– – 0.01% 876
2025
Q4 		$20.3K Hold
414
– – 0.01% 903
2025
Q3 		$17.9K Buy
414
+413
+41,300% +$16.1K 0.01% 931
2025
Q2 		$38 Buy
+1
New +$38 ﹤0.01% 2172

Other funds holding GSK

BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return
Keating Investment Counselors
Keating Investment Counselors Delray Beach, Florida $382M AUM 16.71% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Essential Partners's GSK Position: Q3 2026 in Review

Essential Partners held its GSK (GSK) position steady in Q3 2026 at 414 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #911.

Essential Partners first reported a position in GSK in Q2 2025 and has held it in 6 quarters since. The position peaked at $22.8K in Q1 2026. 235 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Essential Partners held 414 shares of GSK worth $19.9K as of Q3 2026.
  • Essential Partners left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.01% of Essential Partners's portfolio in Q3 2026, its #911 holding.
  • Essential Partners first reported a position in GSK in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's GSK position peaked at $22.8K in Q1 2026.
  • 235 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.